Outlook Worsens For Drug Market As Economic And Industry Factors Unite Against Growth

BMI View: Three main factors govern our outlook for Ukraine's pharmaceutical market in 2012 and 2013: the worsening economic growth prospects, the high potential for devaluation of the hryvnia and signs that the government will introduce a reference pricing system for medicines. While short-term real growth will face obstacles in the coming years, we maintain our positive long-term growth outlook for Ukraine's drug market. For companies willing to shoulder the risks, the market retains huge upside potential and is well situated to access EU and Commonwealth of Independent States markets.

To read the full article, please choose one of the following options: